Clinical Trial: Using Artificial Intelligence to Detect Early Signs of Alzheimer's Disease in People With Memory Concerns

U.S., June 18 -- ClinicalTrials.gov registry received information related to the study (NCT07652931) titled 'Using Artificial Intelligence to Detect Early Signs of Alzheimer's Disease in People With Memory Concerns' on June 08.

Brief Summary: AHEAD is a prospective, longitudinal, risk-stratified single-arm interventional study enrolling 300 patients with Subjective Cognitive Decline (SCD) at IRCCS San Raffaele Hospital, Milan, Italy.

The study uses artificial intelligence (AI) to integrate multimodal data - including MRI, EEG, Optical Coherence Tomography (OCT), neuropsychological assessments, and plasma biomarkers - to identify individuals with underlying Alzheimer's disease (AD) biology and predict cognitive progression.

Only participa...